D46 Categoría · se requiere mayor especificidad Myelodysplastic syndromes
ICD-10-CM D46 identifies “Myelodysplastic syndromes” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Capítulo 2: Neoplasms
Instrucciones del código
Excludes 21
drug-induced aplastic anemia (D61.1)
Use additional code1
code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
Instrucciones de niveles superiores
Capítulos 2 · Neoplasms (C00-D49)
Note8
- Functional activity
- All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- Morphology [Histology]
- Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- Primary malignant neoplasms overlapping site boundaries
- A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- Malignant neoplasm of ectopic tissue
- Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
D37-D48 · Neoplasms of uncertain behavior, polycythemia vera and myelodysplastic syndromes (D37-D48)
Excludes 11
neoplasms of unspecified behavior (D49.-)
Note1
Categories D37-D44, and D48 classify by site neoplasms of uncertain behavior, i.e., histologic confirmation whether the neoplasm is malignant or benign cannot be made.
Códigos más específicos
D46.0Refractory anemia without ring sideroblasts, so statedCódigo facturable y específicoD46.1Refractory anemia with ring sideroblastsCódigo facturable y específicoD46.2Refractory anemia with excess of blasts [RAEB]Categoría · se requiere mayor especificidadD46.4Refractory anemia, unspecifiedCódigo facturable y específicoD46.9Myelodysplastic syndrome, unspecifiedCódigo facturable y específicoD46.ARefractory cytopenia with multilineage dysplasiaCódigo facturable y específicoD46.BRefractory cytopenia with multilineage dysplasia and ring sideroblastsCódigo facturable y específicoD46.CMyelodysplastic syndrome with isolated del(5q) chromosomal abnormalityCódigo facturable y específicoD46.ZOther myelodysplastic syndromesCódigo facturable y específicoReferencias del índice oficial
Referencias desde otros códigos (5)
Excludes 1 · myelodysplastic syndromes (D46.-)
Code also · myelodysplastic syndrome (D46.-)
Excludes 2 · pancytopenia (due to) (with) myelodysplastic syndromes (D46.-)
Excludes 1 · refractory anemia (D46.-)
Use additional code · code, if applicable, for associated therapy-related myelodysplastic syndrome (D46.-)
Historial
Historial del código
Sin cambios desde la primera aparición
Vigente desde
- Primera aparición
Myelodysplastic syndromes
Categoría — seleccione un código más específico
CDC/NCHS · FY2016Todas las ediciones (19)
| Todas las ediciones | Vigente desde | Historial del código |
|---|---|---|
| FY2016 | 2015-10-01 | Primera aparición |
| FY2017 | 2016-10-01 | Sin cambios tabulares |
| FY2018 | 2017-10-01 | Sin cambios tabulares |
| FY2019 | 2018-10-01 | Sin cambios tabulares |
| FY2020 | 2019-10-01 | Sin cambios tabulares |
| FY2020 · April | 2020-04-01 | Sin cambios tabulares |
| FY2021 | 2020-10-01 | Sin cambios tabulares |
| FY2021 · 01-01 | 2021-01-01 | Sin cambios tabulares |
| FY2022 | 2021-10-01 | Sin cambios tabulares |
| FY2022 · 04-01 | 2022-04-01 | Sin cambios tabulares |
| FY2023 | 2022-10-01 | Sin cambios tabulares |
| FY2023 · 04-01 | 2023-04-01 | Sin cambios tabulares |
| FY2024 | 2023-10-01 | Sin cambios tabulares |
| FY2024 · 04-01 | 2024-04-01 | Sin cambios tabulares |
| FY2025 | 2024-10-01 | Sin cambios tabulares |
| FY2025 · 04-01 | 2025-04-01 | Sin cambios tabulares |
| FY2026 | 2025-10-01 | Sin cambios tabulares |
| FY2026 · April | 2026-04-01 | Sin cambios tabulares |
| FY2027 | 2026-10-01 | Sin cambios tabulares |
Explora los códigos más específicos de esta categoría. La comprobación del catálogo no establece la pertinencia clínica ni garantiza el reembolso.